Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-21

Clinical Trial Update: Unilateral Versus Bilateral Neuromodulation Tests in the Treatment of Refractory Idiopathic Overactive Bladder [NA]

View source ↗

Summary

A completed study comparing unilateral versus bilateral neuromodulation for treating refractory idiopathic overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centre Hospitalier Universitaire de Nīmes | Conditions: Urinary Bladder, Overactive | NA | Status: COMPLETED